Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized and Controlled Clinical Study to Evaluate the Efficacy and Safety of Fibrin Sealant VH S/D (FS VH S/D) in Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

NCT00161980 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.

NCT NCT00161980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized and Controlled Clinical Study to Evaluate the Efficacy and Safety of Fibrin Sealant VH S/D (FS VH S/D) in Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites
Lead sponsor
Baxter Healthcare Corporation
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2001
Completion date
December 31, 2002
Enrollment
Not reported
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lumpectomy, lymphatic leakage, mastectomy plus axillary lymph node dissection